Clinical Trial Update: Vascular Inflammation in Psoriasis-Ustekinumab (VIP-U) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on vascular inflammation in psoriasis with ustekinumab has completed and results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Psoriasis

Drugs mentioned

• USTEKINUMAB (USTEKINUMAB)

Snippet

Sponsor: University of Pennsylvania | Conditions: Psoriasis, Cardiovascular Disease | Phase 4 | Status: COMPLETED | Results posted: 2019-08-15